Both initial and maintenance probings are intended to mechanically open Meibomian gland orifices and ducts, remove obstructions, maintain patency of orifices and ducts, restore gland function, increase oil production (qualitatively and quantitatively), and stabilize the tear film, thus relieving symptoms of Meibomian gland dysfunction, blepharitis, ocular rosacea, and dry eye
This observation is consistent with previous studies showing that enhanced antioxidant defenses promote tumor growth in endometrial cancer [22, 23, 29], and further identifies MGST3 as an important molecular link between dysregulated iron metabolism and the survival of endometriotic lesions
As a result, retatrutide is only legally available through clinical trials
There has never been a single registered clinical trial of dihexa in humans